{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:36:31Z","timestamp":1785796591848,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu University Clinical Medical Science and Technology Development Fund (Natural Science) Project 2018","award":["(grant nos. JLY20180034)"],"award-info":[{"award-number":["(grant nos. JLY20180034)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to analyse multiple factors in the prediction of risk of postoperative recurrent vitreous haemorrhage (RVH) for non-clearing vitreous haemorrhage in patients with diabetic retinopathy (DR) who underwent sutureless vitrectomy with 23- (23G) or 25-gauge (25G) narrow-gauge systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective consecutive case series design was used. DR patients who underwent sutureless vitrectomy for non-clearing vitreous haemorrhage between June 2017 and October 2019 were enrolled. All operations were performed at a tertiary hospital. Patient demographics and risk factors, including age, gender, duration of diabetes, preoperative fasting blood sugar levels (FBSL), systolic blood pressure (SBP), serum creatinine (Cr), urea, triamcinolone acetonide (TA), electrical coagulation, air-fluid exchange, pan-retinal photocoagulation status (PRP), anti-vascular endothelial growth factor drug (anti-VEGF), and other factors, were recorded. Patients were divided into two groups based on the timing of their postoperative RVH: immediate postoperative RVH (within 2\u2009weeks after operation) and delayed postoperative RVH (beyond 2\u2009weeks after operation).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 167 eyes (167patients) were enrolled. Seventy eyes were underwent 23G and 25G sutureless vitrectomy performed in 97 eyes, respectively. Postoperative RVH developed in 18 eyes (25.7%) in Group 23G and in 20 eyes (21.6%) in Group 25G (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.540). Of these, 3 eyes (4.3%) had severed RVH in Group 23G compared with 5 eyes (5.2%) in Group 25G (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.584). Delayed postoperative RVH occurred in 6 eyes (8.6%) in Group 23G and 8 eyes (8.2%) in Group 25G (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.789). A binomial logistic regression analysis revealed that age, duration of diabetes, and Cr level were significantly associated with RVH in both Group 23G (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) and Group 25G (P\u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence and severity of RVH were 25.7 and 4.3%, respectively, in Group 23G and 21.6 and 5.2%, respectively, in Group 25G. Thus, the 23G sutureless vitrectomy approach was as safe as the 25G sutureless vitrectomy approach for treating vitreous haemorrhage in patients with DR. A younger age, shorter duration of diabetes, and higher Cr levels were risk factors for postoperative RVH in sutureless vitrectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-020-01532-8","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T13:02:36Z","timestamp":1594904556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuhua","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangtao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"issue":"10","key":"1532_CR1","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.2337\/diacare.27.10.2568","volume":"27","author":"W Rathmann","year":"2004","unstructured":"Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(10):2568\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"1532_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311\u201321.","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"1532_CR3","doi-asserted-by":"publisher","first-page":"s84","DOI":"10.2337\/diacare.27.2007.S84","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl 1):s84\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"1532_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ophtha.2014.08.047","volume":"122","author":"MJ Elman","year":"2015","unstructured":"Elman MJ, Ayala A, Bressler NM, Browning D, Flaxel CJ, Glassman AR, et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. Ophthalmology. 2015;122(2):375\u201381.","journal-title":"Ophthalmology."},{"issue":"4","key":"1532_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789\u2013801.","journal-title":"Ophthalmology."},{"issue":"20","key":"1532_CR6","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/jama.2015.15217","volume":"314","author":"JG Gross","year":"2015","unstructured":"Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314(20):2137\u201346.","journal-title":"JAMA."},{"issue":"7","key":"1532_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamaophthalmol.2014.287","volume":"132","author":"AR Bhavsar","year":"2014","unstructured":"Bhavsar AR, Torres K, Glassman AR, Jampol LM, Kinyoun JL. Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy. JAMA Ophthalmol. 2014;132(7):889\u201390.","journal-title":"JAMA Ophthalmol"},{"key":"1532_CR8","first-page":"865","volume":"17","author":"L Shi","year":"2012","unstructured":"Shi L, Yi-Fei H. Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy. J Res Med Sci. 2012;17:865\u201371.","journal-title":"J Res Med Sci"},{"key":"1532_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bjo.2007.124495","volume":"92","author":"D Yorston","year":"2008","unstructured":"Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92:365\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1532_CR10","first-page":"477","volume":"97","author":"CM Yang","year":"1998","unstructured":"Yang CM. Surgical treatment for diabetic retinopathy: 5-year experience. J Formos Med Assoc. 1998;97:477\u201384.","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"1532_CR11","first-page":"522","volume":"90","author":"AP Schachat","year":"1983","unstructured":"Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy: II. Postoperative complications Ophthalmology. 1983;90(5):522\u201330.","journal-title":"Postoperative complications Ophthalmology"},{"issue":"10","key":"1532_CR12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1097\/IAE.0b013e3181dcfb79","volume":"30","author":"BJ Lee","year":"2010","unstructured":"Lee BJ, Yu HG. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Retina. 2010;30(10):1671\u20137.","journal-title":"Retina."},{"key":"1532_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/02713680903572491","volume":"35","author":"H Yan","year":"2010","unstructured":"Yan H, Cui J, Lu Y, Yu J, Chen S, Xu Y. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy. Curr Eye Res. 2010;35:308\u201313.","journal-title":"Curr Eye Res"},{"key":"1532_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0181-5512(05)81068-X","volume":"28","author":"M Zaninetti","year":"2005","unstructured":"Zaninetti M, Petropoulos IK, Pournaras CJ. Proliferative diabetic retinopathy: Vitreo-retinal complications are often related to insufficient retinal photocoagulation. J Fr Ophtalmol. 2005;28:381\u20134.","journal-title":"J Fr Ophtalmol"},{"key":"1532_CR15","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0161-6420(02)01119-3","volume":"109","author":"GY Fujii","year":"2002","unstructured":"Fujii GY, De Juan E Jr, Humayun MS, Chang TS, Pieramici DJ, Barnes A, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002;109:1814\u201320.","journal-title":"Ophthalmology"},{"key":"1532_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF01203852","volume":"87","author":"P Sima","year":"1994","unstructured":"Sima P, Zoran T. Long-term results of vitreous surgery for proliferative diabetic retinopathy. Doc Ophthalmol. 1994;87:223\u201332.","journal-title":"Doc Ophthalmol"},{"key":"1532_CR17","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.ophtha.2005.07.010","volume":"112","author":"PT Yeh","year":"2005","unstructured":"Yeh PT, Yang CM, Yang CH, Huang JS. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study. Ophthalmology. 2005;112:2095\u2013102.","journal-title":"Ophthalmology"},{"key":"1532_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajo.2012.11.004","volume":"155","author":"MK Khuthaila","year":"2013","unstructured":"Khuthaila MK, Hsu J, Chiang A, DeCroos FC, Milder EA, Setlur V, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2013;155:757\u201363 763.e1\u20132.","journal-title":"Am J Ophthalmol"},{"key":"1532_CR19","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0161-6420(89)32700-X","volume":"96","author":"FI Tolentino","year":"1989","unstructured":"Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology. 1989;96:1495\u2013500.","journal-title":"Ophthalmology"},{"key":"1532_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retiopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1532_CR21","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. Jama. 2013;310(9):948\u201359.","journal-title":"Jama."},{"issue":"12","key":"1532_CR22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090\u2013101.","journal-title":"N Engl J Med"},{"issue":"16","key":"1532_CR23","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1001\/jama.1976.03270170027020","volume":"236","author":"MJ Kussman","year":"1976","unstructured":"Kussman MJ, Goldstein H, Gleason RE. The clinical course of diabetic nephropathy. JAMA. 1976;236(16):1861\u20133.","journal-title":"JAMA"},{"key":"1532_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4103\/ijo.IJO_770_17","volume":"66","author":"P Mahalingam","year":"2018","unstructured":"Mahalingam P, Topiwalla TT, Ganesan G. Vitreous rebleed following sutureless vitrectomy: incidence and risk factors. Indian J Ophthalmol. 2018;66:558\u201361.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"1532_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ophtha.2006.07.047","volume":"114","author":"CM Yang","year":"2007","unstructured":"Yang CM, Yeh PT, Yang CH. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology. 2007;114(4):710\u20135.","journal-title":"Ophthalmology"},{"key":"1532_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/IAE.0b013e3181934908","volume":"29","author":"M Nagpal","year":"2009","unstructured":"Nagpal M, Wartikar S, Nagpal K. Comparison of clinical outcomes and wound dynamics of sclerotomy ports of 20, 25, and 23 gauge vitrectomy. Retina. 2009;29:225\u201331.","journal-title":"Retina"},{"key":"1532_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/IAE.0b013e3181853d3c","volume":"28","author":"T Altan","year":"2008","unstructured":"Altan T, Acar N, Kapran Z, Unver YB, Ozdogan S. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment. Retina. 2008;28:1201\u20136.","journal-title":"Retina"},{"issue":"2","key":"1532_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","volume":"146","author":"CM Yang","year":"2008","unstructured":"Yang CM, Yeh PT, Yang CH, Chen MS. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol. 2008;146(2):211\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1532_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","volume":"246","author":"S Rizzo","year":"2008","unstructured":"Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol. 2008;246(6):837\u201342.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1532_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/08820538.2013.835847","volume":"30","author":"S Berk Ergun","year":"2015","unstructured":"Berk Ergun S, Toklu Y, Cakmak HB, Raza S, Simsek S. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage. Semin Ophthalmol. 2015;30(3):177\u201380.","journal-title":"Semin Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01532-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01532-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01532-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:33:57Z","timestamp":1626377637000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01532-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01532-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-21982\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the ethics committee of Jiangsu Province Hospital, and informed written consent had been obtained from the patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}